Aerobic training in patients with anoctamin 5 myopathy and hyperckemia

26Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: Anoctamin 5 deficiency has recently been defined to cause limb-girdle muscular dystrophy type 2L (LGMD2L) with pronounced hyperCKemia. No treatment interventions have been made so far in this condition. Methods: In 6 patients with LGMD2L, we studied the effect of home-based, pulse-watch monitored, moderate-intensity exercise on a cycle ergometer for 30 minutes, 3 times weekly, for 10 weeks. Plasma creatine kinase (CK) was assessed before, during, and after the program as a marker of muscle damage. Primary outcome measures were maximum oxygen uptake (VO2max) and time in the 5-repetitions-sit-to-stand test (FRSTST). Results: Training resulted in improvements in VO2max (27±7%; P=0.0001) and FRSTST time (35±12%; P=0.007). Improvements in physiologic and functional muscle testing were accompanied by stable CK levels and no reports of adverse effects. Conclusions: These findings suggest that supervised aerobic exercise training is safe and effective in improving oxidative capacity and muscle function in patients with anoctamin 5 deficiency. © 2013 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Vissing, C. R., Preisler, N., Husu, E., Prahm, K. P., & Vissing, J. (2014). Aerobic training in patients with anoctamin 5 myopathy and hyperckemia. Muscle and Nerve, 50(1), 119–123. https://doi.org/10.1002/mus.24112

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free